TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 33nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 37nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 47nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 58nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 64nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 68nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 69nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 90nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 96nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 97nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 121nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 138nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 155nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 160nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 175nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 179nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 211nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 232nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 238nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 238nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 275nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 287nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 298nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 320nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 320nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 325nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 340nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 350nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 365nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair